Home
About
Science
Pipeline
Clinical Trials
Partnerships
Investors
News

News/Redeye initiates coverage of Lytix Biopharma

News

News

Press releases & other news Subscribe

Aug 10, 2023

Redeye initiates coverage of Lytix Biopharma

Find the Research Report here

Oncolytic Molecules that Kill Cancer with Direct & Abscopal Tumor Effects

Oslo, Norway

Company

About
Management Team
Board of Directors
Scientific Advisory Board

Science

Our Science
Pipeline
Publications
Posters

Resources

Clinical Trials
News & Events
Investor Relations

Connect

Partnerships
Contact

Partner With Us

© 2026 Lytix Biopharma AS. All rights reserved.

Privacy PolicyTerms and Conditions Disclaimer